165 related articles for article (PubMed ID: 31146251)
1. Establishment of an induced pluripotent stem cell line (FRIMOi005-A) derived from a retinitis pigmentosa patient carrying a dominant mutation in RHO gene.
Domingo-Prim J; Riera M; Burés-Jelstrup A; Corcostegui B; Pomares E
Stem Cell Res; 2019 Jul; 38():101468. PubMed ID: 31146251
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of an iPSC line (FRIMOi001-A) derived from a retinitis pigmentosa patient carrying PDE6A mutations.
Riera M; Patel A; Corcostegui B; Chang S; Sparrow JR; Pomares E; Corneo B
Stem Cell Res; 2019 Mar; 35():101385. PubMed ID: 30685614
[TBL] [Abstract][Full Text] [Related]
3. Generation of an induced pluripotent stem cell line (FRIMOi002-A) from a retinitis pigmentosa patient carrying compound heterozygous mutations in USH2A gene.
Riera M; Patel A; Corcostegui B; Chang S; Corneo B; Sparrow JR; Pomares E
Stem Cell Res; 2019 Mar; 35():101386. PubMed ID: 30685615
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.
Zhang X; Moon SY; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; McLenachan S; Chen FK
Stem Cell Res; 2019 May; 37():101452. PubMed ID: 31059986
[TBL] [Abstract][Full Text] [Related]
5. Generation of a human iPSC line from a patient with retinitis pigmentosa caused by mutation in PRPF8 gene.
Lukovic D; Bolinches-Amorós A; Artero-Castro A; Pascual B; Carballo M; Hernan I; Erceg S
Stem Cell Res; 2017 May; 21():23-25. PubMed ID: 28677533
[TBL] [Abstract][Full Text] [Related]
6. Generation of an induced pluripotent stem cell (iPSC) line from a patient with autosomal dominant retinitis pigmentosa due to a mutation in the NR2E3 gene.
Terray A; Slembrouck A; Nanteau C; Chondroyer C; Zeitz C; Sahel JA; Audo I; Reichman S; Goureau O
Stem Cell Res; 2017 Oct; 24():1-4. PubMed ID: 29034877
[TBL] [Abstract][Full Text] [Related]
7. Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling.
Jin ZB; Okamoto S; Xiang P; Takahashi M
Stem Cells Transl Med; 2012 Jun; 1(6):503-9. PubMed ID: 23197854
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of the human iPSC line CABi001-A from a patient with retinitis pigmentosa caused by a novel mutation in PRPF31 gene.
de la Cerda B; Díez-Lloret A; Ponte B; Vallés-Saiz L; Calado SM; Rodríguez-Bocanegra E; Garcia-Delgado AB; Moya-Molina M; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2019 Apr; 36():101426. PubMed ID: 30921587
[TBL] [Abstract][Full Text] [Related]
9. Generation of an iPSC line from a retinitis pigmentosa patient carrying a homozygous mutation in CERKL and a healthy sibling.
Bolinches-Amorós A; León M; Del Buey Furió V; Marfany G; Gonzàlez-Duarte R; Erceg S; Lukovic D
Stem Cell Res; 2019 Jul; 38():101455. PubMed ID: 31082679
[TBL] [Abstract][Full Text] [Related]
10. Generation of an iPS cell line via a non-integrative method using urine-derived cells from a patient with USH2A-associated retinitis pigmentosa.
Guo Y; Zeng Q; Liu S; Yu Q; Wang P; Ma H; Shi S; Yan X; Cui Z; Xie M; Xue Y; Zha Q; Li Z; Zhang J; Tang S; Chen J
Stem Cell Res; 2018 May; 29():139-142. PubMed ID: 29660607
[TBL] [Abstract][Full Text] [Related]
11. Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.
Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2018 Aug; 31():147-151. PubMed ID: 30092450
[TBL] [Abstract][Full Text] [Related]
12. Establishment of an induced pluripotent stem (iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation.
Terray A; Fort V; Slembrouck A; Nanteau C; Sahel JA; Reichman S; Audo I; Goureau O
Stem Cell Res; 2017 Dec; 25():26-29. PubMed ID: 29040912
[TBL] [Abstract][Full Text] [Related]
13. Generation of Best disease-derived induced pluripotent stem cell line (FRIMOi006-A) carrying a novel dominant mutation in BEST1 gene.
Domingo-Prim J; Riera M; Abad-Morales V; Ruiz-Nogales S; Corcostegui B; Pomares E
Stem Cell Res; 2019 Oct; 40():101570. PubMed ID: 31518904
[TBL] [Abstract][Full Text] [Related]
14. Establishment of non-integrate induced pluripotent stem cell line CSUASOi006-A, from urine-derived cells of a PRPF8-related dominant retinitis pigmentosa patient.
Zhou Y; Cui Z; Jing Y; Mao S; Chen D; Ding C; Gu J; Chan HF; Tang S; Chen J
Stem Cell Res; 2020 Dec; 49():102041. PubMed ID: 33157387
[TBL] [Abstract][Full Text] [Related]
15. Deterioration of phagocytosis in induced pluripotent stem cell-derived retinal pigment epithelial cells established from patients with retinitis pigmentosa carrying Mer tyrosine kinase mutations.
Tagawa M; Ikeda HO; Inoue Y; Iwai S; Iida Y; Hata M; Asaka I; Tsujikawa A
Exp Eye Res; 2021 Apr; 205():108503. PubMed ID: 33609509
[TBL] [Abstract][Full Text] [Related]
16. Generation of a human iPS cell line from a patient with retinitis pigmentosa due to EYS mutation.
Calado SM; Garcia-Delgado AB; De la Cerda B; Ponte-Zuñiga B; Bhattacharya SS; Díaz-Corrales FJ
Stem Cell Res; 2018 Dec; 33():251-254. PubMed ID: 30471616
[TBL] [Abstract][Full Text] [Related]
17. Generation of the induced pluripotent stem cell line IOCVi001-A from a patient with the MFRP-related retinitis pigmentosa-nanophthalmos syndrome.
Mora-Roldan GA; Nava J; Gazarian K; Zenteno JC
Stem Cell Res; 2024 Mar; 75():103309. PubMed ID: 38217995
[TBL] [Abstract][Full Text] [Related]
18. Structural Variants Create New Topological-Associated Domains and Ectopic Retinal Enhancer-Gene Contact in Dominant Retinitis Pigmentosa.
de Bruijn SE; Fiorentino A; Ottaviani D; Fanucchi S; Melo US; Corral-Serrano JC; Mulders T; Georgiou M; Rivolta C; Pontikos N; Arno G; Roberts L; Greenberg J; Albert S; Gilissen C; Aben M; Rebello G; Mead S; Raymond FL; Corominas J; Smith CEL; Kremer H; Downes S; Black GC; Webster AR; Inglehearn CF; van den Born LI; Koenekoop RK; Michaelides M; Ramesar RS; Hoyng CB; Mundlos S; Mhlanga MM; Cremers FPM; Cheetham ME; Roosing S; Hardcastle AJ
Am J Hum Genet; 2020 Nov; 107(5):802-814. PubMed ID: 33022222
[TBL] [Abstract][Full Text] [Related]
19. Derivation of familial iPSC lines from three patients with retinitis pigmentosa carrying an autosomal dominant RPE65 mutation (NUIGi027-A, NUIGi028-A, NUIGi029-A).
Ding Y; Carvalho E; Murphy C; McInerney V; Krawczyk J; O'Brien T; Howard L; Cai L; Shen S
Stem Cell Res; 2020 Mar; 43():101665. PubMed ID: 31954326
[TBL] [Abstract][Full Text] [Related]
20. Establishment of induced pluripotent stem cell line CSUASOi004-A by reprogramming peripheral blood mononuclear cells of a PRPF6-related dominant retinitis pigmentosa patient.
Zhou Y; Jing Y; Mao S; Liu J; Cui Z; Wang Y; Chen J; Chan HF; Tang S; Chen J
Stem Cell Res; 2020 May; 45():101793. PubMed ID: 32335390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
